WWP1 targets HER4 CYT1 for ubiquitination and degradation, thereby preventing HER4 signaling and breast tumorigenesis [108], which could have implications for developing therapies aimed at modulating HER4 signaling in breast cancer. Here, ERBB4 is linked to breast carcinoma.